Availability of Serum Type I Collagen Degradation Product (ICTP) in the Diagnosis of bone Metastasis in Primary Lung Cancer

Rieko Kondo, Soichi Tachikawa, Takahiko Horiguchi

研究成果: Article査読

抄録

In order to establish the diagnosis of bone metastasis in patients with primary lung cancer, serum type I collagen degradation product (ICTP), a metabolite of type I collagen which consists more than 90% of the organic substance of the bone, was measured and its clinical availability was evaluated by comparing these values with values of serum CEA, CYFRA21-1, alkaline phosphatase and calcium, whitch were simultaneously measured. The serum ICTP levels in the patients with lung cancer with bone metastasis were significantly elevated, compared with those patients without bone metastasis and patients with other pulmonary diseases and healthy controls. It also showed decided superiority over the others in sensitivity and specificity. The results suggested the usability in the diagnosis of bone metastasis in lung cancer.

本文言語English
ページ(範囲)942-943
ページ数2
ジャーナルJapanese Journal of Chest Diseases
57
11
出版ステータスPublished - 01-12-1998

All Science Journal Classification (ASJC) codes

  • 呼吸器内科

フィンガープリント

「Availability of Serum Type I Collagen Degradation Product (ICTP) in the Diagnosis of bone Metastasis in Primary Lung Cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル